维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Mackean"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Interventions for the treatment of borderline ovarian tumours 显示文摘	Faluyi O Mackean M Gourley C	2010	Cochrane Database Syst Rev2010，，00：	1
2	A role for methyl lationof the hMLH, promoter in loss of hMLH, expression and drugresitene in ovarian cancer 显示文摘	Strathdee G Mackean M J Illand M	1999	Oncogene1999，18，：	1
3	Phase Ⅰ and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer显示文摘	Mackean M Planting A Twelves C	1998	J Clin Oncol1998，16，9：	1
4	Reversal of dose- limiting carboplatin-induced peripheral neuropathy with TR- PM8 activator,menthol,enables further effective chemothera- py delivery显示文摘	Storey DJ Colvin LA Mackean MJ	2010	J Pain Symptom Manage2010，39，：	1
5	Interventions for the treatment of borderline ovarian tumours显示文摘	Faluyi O Mackean M Gourley C	2010	Cochrane Database Syst Rev2010，，00：	1
6	A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer显示文摘	Strathdee G MacKean M J Illand M	1999	Oncogene1999，18，14：	1
7	Phase Ⅰ and pharmacologic study of intermittent twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer显示文摘	MacKean M J Planting A S Twelves C	1998	J Clin Oncol1998，16，9：	1
8	Improving outcomes for limited stage small cell lung cancer patients in Scotland with concomitant chemoradiation 显示文摘	Law AB Erridge SC MacKean MJ	2007	J Clin Oncol ( R Coil Radiol)2007，19，3：	1
9	Improving outcomes for limited stage small cell lung cancer patients in Scotland with concomitant chemoradiation显示文摘	Law AB Erridge SC MacKean MJ	2007	J Clin Oncol ( R Coil Radiol)2007，19，3：	1
10	A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer 显示文摘	Strathdee G MacKean MJ Illand M	1999	Oncogene1999，18，14：	1
11	Phase I and pharmacologic study of intermittenttwice-daily oral therapy with capecitabinein patients with advanced and/or metastaticcancer显示文摘	MACKEAN M PLANTING A TWELVES C	1998	y CUn Oncol1998，16，9：	1
12	Interventions for the treat-ment of borderline ovarian tumours 显示文摘	Faluyi O Mackean M Gourley C	2010	Cochrane Database Syst Rev2010，8，9：	1
13	A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer显示文摘	Strathdee G MacKean MJ Illand M Brown R	1999	Oncogene1999，18，：	1
14	Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer 显示文摘	Mackean M Planting A Twelves C	1998	J Clin Oncol1998，16，9：	1
15	Phase I and phamacological study of intemittent twice - daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer 显示文摘	Mackean MJ Planting AS Twelves C	1998	J Clin Oncol1998，16，29：	1
16	A role for m- ethylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer 显示文摘	STRATHDEE G MACKEAN M ILLAND M	1999	Oncogene1999，18，14：	1
17	Interventions for the treatment of borderline ovarian tumours显示文摘	Faluyi O Mackean M Gourley C	2010	Cochrane Database Syst Rev2010，，00：	1
18	Phase Ⅰ and pharmacologic study of intermitten twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer显示文摘	Planting A Twelves C	1998	J Clin Oncol1998，16，9：	1
19	Positive epis-tasis between co-infecting plasmids promotes plasmid survival in bacterial populations显示文摘	MILLAN A S HEIBRON K MACKEAN R C	2014	Multidisciplinary Journal of Microbial Ecology2014，8，3：	1
20	Phase I and pharmacologic study of intermitten twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer 显示文摘	Mackean M Planting A Twelves C	1998	J Clin Oneol1998，16，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示